Retail sale of pharmaceutical products
ANKER APOTEK AS
Revenue 2024
NOK 11.7m
Operating profit
NOK 198,000
Equity
NOK 836,000
Incorporated
2012
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.38
Equity ratio
31.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 1.7% | |
| Net margin (%%) | 1.2% | |
| Return on assets (%%) | 7.3% | |
| Likviditet | ||
| Current ratio | 1.38 | |
| Working capital | 696k | |
| Soliditet | ||
| Equity ratio (%%) | 31.0% | |
| Debt-to-equity ratio | 2.22 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.